BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ballester B, Milara J, Cortijo J. Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. Int J Mol Sci 2019;20:E593. [PMID: 30704051 DOI: 10.3390/ijms20030593] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Lashari BH, Vender RJ, Fleitas-sosa DC, Sinha T, Criner GJ. Lung cancer in recipients after lung transplant: single-centre experience and literature review. BMJ Open Resp Res 2022;9:e001194. [DOI: 10.1136/bmjresp-2021-001194] [Reference Citation Analysis]
2 Young ARJ, Cassidy LD, Narita M. Autophagy and senescence, converging roles in pathophysiology as seen through mouse models. Adv Cancer Res 2021;150:113-45. [PMID: 33858595 DOI: 10.1016/bs.acr.2021.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xu Y, Peng W, Han D, Feng F, Wang Z, Gu C, Zhou X, Wu Q. Maiwei Yangfei decoction prevents bleomycin-induced pulmonary fibrosis in mice. Exp Ther Med 2021;22:1306. [PMID: 34630661 DOI: 10.3892/etm.2021.10741] [Reference Citation Analysis]
4 Yang S, Liu P, Jiang Y, Wang Z, Dai H, Wang C. Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis. Front Cell Dev Biol 2021;9:639657. [PMID: 33768094 DOI: 10.3389/fcell.2021.639657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 García-Fernández A, Sancenón F, Martínez-Máñez R. Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev 2021;177:113953. [PMID: 34474094 DOI: 10.1016/j.addr.2021.113953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
6 Galioto F, Palmucci S, Astuti GM, Vancheri A, Distefano G, Tiralongo F, Libra A, Cusumano G, Basile A, Vancheri C. Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features. Diagnostics (Basel) 2020;10:E450. [PMID: 32635390 DOI: 10.3390/diagnostics10070450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xu C, Hou L, Zhao J, Wang Y, Jiang F, Jiang Q, Zhu Z, Tian L. Exosomal let-7i-5p from three-dimensional cultured human umbilical cord mesenchymal stem cells inhibits fibroblast activation in silicosis through targeting TGFBR1. Ecotoxicol Environ Saf 2022;233:113302. [PMID: 35189518 DOI: 10.1016/j.ecoenv.2022.113302] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kalinke L, Thakrar R, Janes SM. The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers. Mol Oncol 2021;15:2544-64. [PMID: 33252175 DOI: 10.1002/1878-0261.12864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Togami K, Ogasawara A, Irie S, Iwata K, Yamaguchi K, Tada H, Chono S. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.02.009] [Reference Citation Analysis]
10 Sun CC, Zhou ZQ, Yang D, Chen ZL, Zhou YY, Wen W, Feng C, Zheng L, Peng XY, Tang CF. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Int Immunopharmacol 2021;101:108176. [PMID: 34655851 DOI: 10.1016/j.intimp.2021.108176] [Reference Citation Analysis]
11 Yao Y, Li Z, Gao W. Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis. Front Genet 2022;13:855789. [DOI: 10.3389/fgene.2022.855789] [Reference Citation Analysis]
12 Romero Y, Aquino-Gálvez A. Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution. Int J Mol Sci 2021;22:8335. [PMID: 34361103 DOI: 10.3390/ijms22158335] [Reference Citation Analysis]
13 Yoneshima Y, Iwama E, Matsumoto S, Matsubara T, Tagawa T, Ota K, Tanaka K, Takenoyama M, Okamoto T, Goto K, Mori M, Okamoto I. Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis. Sci Rep 2021;11:12732. [PMID: 34140559 DOI: 10.1038/s41598-021-92098-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Luo J, Zhang T, Zhu C, Sun J, Zhu W, Ai W, Huang X, Wang X. Asiaticoside might attenuate bleomycin-induced pulmonary fibrosis by activating cAMP and Rap1 signalling pathway assisted by A2AR. J Cell Mol Med 2020;24:8248-61. [PMID: 32548952 DOI: 10.1111/jcmm.15505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Gu C, Shi X, Dang X, Chen J, Chen C, Chen Y, Pan X, Huang T. Identification of Common Genes and Pathways in Eight Fibrosis Diseases. Front Genet 2020;11:627396. [PMID: 33519923 DOI: 10.3389/fgene.2020.627396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
16 Diazzi S, Tartare-Deckert S, Deckert M. Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies. Cancers (Basel) 2020;12:E1364. [PMID: 32466585 DOI: 10.3390/cancers12061364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
17 Hamanaka RB, Mutlu GM. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer. Amino Acids 2021. [PMID: 33963932 DOI: 10.1007/s00726-021-02996-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Moustafa EM, Ismail Ibrahim S, Salem FA. Methylsulfonylmethane inhibits lung fibrosis progression, inflammatory response, and epithelial-mesenchymal transition via the transforming growth factor-Β1/SMAD2/3 pathway in rats exposed to both γ -radiation and Bisphenol-A. Toxin Reviews. [DOI: 10.1080/15569543.2020.1728337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ashtiwi NM, Sarr D, Rada B. DUOX1 in mammalian disease pathophysiology. J Mol Med (Berl) 2021;99:743-54. [PMID: 33704512 DOI: 10.1007/s00109-021-02058-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang Y, Jin, Kang X, Zhou R, Sun Y, Lian F, Tong X. Signaling Pathways Involved in Diabetic Renal Fibrosis. Front Cell Dev Biol 2021;9:696542. [PMID: 34327204 DOI: 10.3389/fcell.2021.696542] [Reference Citation Analysis]
21 Papoutsopoulou S, Satsangi J, Campbell BJ, Probert CS. Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms. Aliment Pharmacol Ther 2020;51:1268-85. [PMID: 32372449 DOI: 10.1111/apt.15774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
22 Guo X, Sunil C, Adeyanju O, Parker A, Huang S, Ikebe M, Tucker TA, Idell S, Qian G. PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways. Sci Rep 2022;12:3053. [PMID: 35197539 DOI: 10.1038/s41598-022-07044-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Niel C, Ricordel C, Guy T, Kerjouan M, De Latour B, Chiforeanu D, Lederlin M, Jouneau S. Idiopathic pulmonary fibrosis diagnosed concomitantly with diffuse squamous cell lung cancer on surgical lung biopsy: a case report. J Med Case Rep 2021;15:595. [PMID: 34906240 DOI: 10.1186/s13256-021-03177-7] [Reference Citation Analysis]
24 Eni-Aganga I, Lanaghan ZM, Balasubramaniam M, Dash C, Pandhare J. PROLIDASE: A Review from Discovery to its Role in Health and Disease. Front Mol Biosci 2021;8:723003. [PMID: 34532344 DOI: 10.3389/fmolb.2021.723003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Nagy A, Müller V, Kolonics-Farkas AM, Eszes N, Vincze K, Horvath G. Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis. Thorac Cancer 2019;10:1819-26. [PMID: 31317672 DOI: 10.1111/1759-7714.13153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li N, Qiu L, Zeng C, Fang Z, Chen S, Song X, Song H, Zhang G. Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis. Ann Transl Med 2021;9:1459. [PMID: 34734011 DOI: 10.21037/atm-21-4224] [Reference Citation Analysis]
27 Jang HJ, Park MS, Kim YS, Chang J, Lee JH, Lee CT, Lee SH, Yoon HI. The relationship between the severity of pulmonary fibrosis and the lung cancer stage. J Cancer 2021;12:2807-14. [PMID: 33854581 DOI: 10.7150/jca.51445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Parker AL, Cox TR. The Role of the ECM in Lung Cancer Dormancy and Outgrowth. Front Oncol 2020;10:1766. [PMID: 33014869 DOI: 10.3389/fonc.2020.01766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
29 Wu D, Gao W, Li X, Tian C, Jiao N, Fang S, Xiao J, Xu Z, Zhu L, Zhang G, Zhu R. Dr AFC: drug repositioning through anti-fibrosis characteristic. Brief Bioinform 2021;22:bbaa115. [PMID: 32572450 DOI: 10.1093/bib/bbaa115] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kang H, Choi SM. Diagnosis and treatment of interstitial lung disease: focusing on idiopathic pulmonary fibrosis. J Korean Med Assoc 2020;63:159. [DOI: 10.5124/jkma.2020.63.3.159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Liu X, Shao Y, Zhang X, Ji X, Xie M, Liu H. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway. Acta Histochem 2021;123:151746. [PMID: 34217047 DOI: 10.1016/j.acthis.2021.151746] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yamato H, Kimura K, Fukui E, Kanou T, Ose N, Funaki S, Minami M, Shintani Y. Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer. Sci Rep 2021;11:21114. [PMID: 34702952 DOI: 10.1038/s41598-021-00717-5] [Reference Citation Analysis]
33 Kou W, Li B, Shi Y, Zhao Y, Yu Q, Zhuang J, Xu Y, Peng W. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis. BMC Cancer 2022;22:110. [PMID: 35078421 DOI: 10.1186/s12885-021-08912-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Yu DH, Ruan XL, Huang JY, Liu XP, Ma HL, Chen C, Hu WD, Li S. Analysis of the Interaction Network of Hub miRNAs-Hub Genes, Being Involved in Idiopathic Pulmonary Fibers and Its Emerging Role in Non-small Cell Lung Cancer. Front Genet 2020;11:302. [PMID: 32300359 DOI: 10.3389/fgene.2020.00302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Axelsson GT, Putman RK, Aspelund T, Gudmundsson EF, Hida T, Araki T, Nishino M, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G. The associations of interstitial lung abnormalities with cancer diagnoses and mortality. Eur Respir J 2020;56:1902154. [PMID: 32646918 DOI: 10.1183/13993003.02154-2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Zhu K, Xu A, Xia W, Li P, Han R, Wang E, Zhou S, Wang R. Integrated analysis of the molecular mechanisms in idiopathic pulmonary fibrosis. Int J Med Sci 2021;18:3412-24. [PMID: 34522168 DOI: 10.7150/ijms.61309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Qin L, Gabazza EC. Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges. Int J Mol Sci 2019;20:E4313. [PMID: 31484418 DOI: 10.3390/ijms20174313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Altorki NK, Borczuk AC, Harrison S, Groner LK, Bhinder B, Mittal V, Elemento O, McGraw TE. Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma. Cell Rep 2022;39:110639. [PMID: 35385730 DOI: 10.1016/j.celrep.2022.110639] [Reference Citation Analysis]
39 Yin D, Qiu J, Hu S, Cheng L, Li H, Cheng X, Wang S, Lu J. CAV1 is a prognostic predictor for patients with idiopathic pulmonary fibrosis and lung cancer. J Biosci 2022;47. [DOI: 10.1007/s12038-021-00245-4] [Reference Citation Analysis]
40 Carraro G, Mulay A, Yao C, Mizuno T, Konda B, Petrov M, Lafkas D, Arron JR, Hogaboam CM, Chen P, Jiang D, Noble PW, Randell SH, McQualter JL, Stripp BR. Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs. Am J Respir Crit Care Med 2020;202:1540-50. [PMID: 32692579 DOI: 10.1164/rccm.201904-0792OC] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 16.5] [Reference Citation Analysis]
41 Bersimbaev R, Pulliero A, Bulgakova O, Asia K, Aripova A, Izzotti A. Radon Biomonitoring and microRNA in Lung Cancer. Int J Mol Sci 2020;21:E2154. [PMID: 32245099 DOI: 10.3390/ijms21062154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
42 Lettieri S, Oggionni T, Lancia A, Bortolotto C, Stella GM. Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? Int J Mol Sci 2021;22:2882. [PMID: 33809111 DOI: 10.3390/ijms22062882] [Reference Citation Analysis]
43 Leng D, Yi J, Xiang M, Zhao H, Zhang Y. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling. BMC Cancer 2020;20:986. [PMID: 33046043 DOI: 10.1186/s12885-020-07494-w] [Reference Citation Analysis]
44 Lu Y, Zhong W, Liu Y, Chen W, Zhang J, Zeng Z, Huang H, Qiao Y, Wan X, Meng X, Cai S, Dong H. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Int Immunopharmacol 2022;104:108504. [PMID: 35026657 DOI: 10.1016/j.intimp.2021.108504] [Reference Citation Analysis]
45 Alfaro TM, Robalo Cordeiro C. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us? Ther Adv Respir Dis 2020;14:1753466620910092. [PMID: 32167024 DOI: 10.1177/1753466620910092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Okano N, Kubo N, Yamaguchi K, Kouno S, Miyasaka Y, Mizukami T, Shirai K, Saitoh JI, Ebara T, Kawamura H, Maeno T, Ohno T. Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease. Cancers (Basel) 2021;13:4204. [PMID: 34439358 DOI: 10.3390/cancers13164204] [Reference Citation Analysis]
47 Nojima Y, Takeda Y, Maeda Y, Bamba T, Fukusaki E, Itoh MN, Mizuguchi K, Kumanogoh A. Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis. FEBS Open Bio 2020;10:2427-36. [PMID: 32961634 DOI: 10.1002/2211-5463.12982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Jo HG, Park C, Lee H, Kim GY, Keum YS, Hyun JW, Kwon TK, Choi YH, Hong SH. Inhibition of oxidative stress induced-cytotoxicity by coptisine in V79-4 Chinese hamster lung fibroblasts through the induction of Nrf-2 mediated HO-1 expression. Genes Genomics 2021;43:17-31. [PMID: 33237503 DOI: 10.1007/s13258-020-01018-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chang CJ, Lin CF, Lee CH, Chuang HC, Shih FC, Wan SW, Tai C, Chen CL. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis. Biochem Pharmacol 2021;183:114356. [PMID: 33285108 DOI: 10.1016/j.bcp.2020.114356] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Li X, Yu H, Liang L, Bi Z, Wang Y, Gao S, Wang M, Li H, Miao Y, Deng R, Ma L, Luan J, Li S, Liu M, Lin J, Zhou H, Yang C. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β. Biochem Pharmacol 2020;178:114097. [PMID: 32535102 DOI: 10.1016/j.bcp.2020.114097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
51 Sun B, Liu X, Zheng X, Wang C, Meng Q, Sun H, Shu X, Liu K, Sun X, Li Y, Ma X. Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). ChemMedChem 2020;15:182-7. [PMID: 31755225 DOI: 10.1002/cmdc.201900606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Yioe V, Phillips G, Spencer LG. Interstitial lung disease on the acute take for the non-respiratory physician. Clin Med (Lond) 2021;21:e584-90. [PMID: 34862217 DOI: 10.7861/clinmed.2021-0694] [Reference Citation Analysis]
53 Cheng J, Eroglu A. The Promising Effects of Astaxanthin on Lung Diseases. Adv Nutr 2021;12:850-64. [PMID: 33179051 DOI: 10.1093/advances/nmaa143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Duitman J, van den Ende T, Spek CA. Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis? J Clin Med 2019;8:E1547. [PMID: 31561518 DOI: 10.3390/jcm8101547] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
55 Geisslinger F, Vollmar AM, Bartel K. Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa? Pharmaceuticals (Basel) 2020;13:E143. [PMID: 32640723 DOI: 10.3390/ph13070143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
56 Gong H, Zheng C, Lyu X, Dong L, Tan S, Zhang X. Inhibition of Sirt2 Alleviates Fibroblasts Activation and Pulmonary Fibrosis via Smad2/3 Pathway. Front Pharmacol 2021;12:756131. [PMID: 34925016 DOI: 10.3389/fphar.2021.756131] [Reference Citation Analysis]
57 Geng J, Liu Y, Dai H, Wang C. Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis. Front Physiol 2022;12:794629. [DOI: 10.3389/fphys.2021.794629] [Reference Citation Analysis]
58 Ramachandran S, Verma AK, Dev K, Goyal Y, Bhatt D, Alsahli MA, Rahmani AH, Almatroudi A, Almatroodi SA, Alrumaihi F, Khan NA. Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation. Oxid Med Cell Longev 2021;2021:5563746. [PMID: 34336101 DOI: 10.1155/2021/5563746] [Reference Citation Analysis]
59 Lv M, Liu Y, Ma S, Yu Z. Current advances in idiopathic pulmonary fibrosis: the pathogenesis, therapeutic strategies and candidate molecules. Future Medicinal Chemistry 2019;11:2595-620. [DOI: 10.4155/fmc-2019-0111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
60 Barczi E, Nagy T, Starobinski L, Kolonics-Farkas A, Eszes N, Bohacs A, Tarnoki AD, Tarnoki DL, Müller V. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival. Thorac Cancer 2020;11:1911-7. [PMID: 32401433 DOI: 10.1111/1759-7714.13481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Alsharairi NA. Scutellaria baicalensis and Their Natural Flavone Compounds as Potential Medicinal Drugs for the Treatment of Nicotine-Induced Non-Small-Cell Lung Cancer and Asthma. Int J Environ Res Public Health 2021;18:5243. [PMID: 34069141 DOI: 10.3390/ijerph18105243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wu B, Sodji QH, Oyelere AK. Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers 2022;14:552. [DOI: 10.3390/cancers14030552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
63 Clifford LM, Li J, Renaud CJ, Fernando SL. Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease. Case Rep Rheumatol 2019;2019:2673947. [PMID: 31976114 DOI: 10.1155/2019/2673947] [Reference Citation Analysis]
64 Wang C, Yang J. Mechanical forces: The missing link between idiopathic pulmonary fibrosis and lung cancer. European Journal of Cell Biology 2022;101:151234. [DOI: 10.1016/j.ejcb.2022.151234] [Reference Citation Analysis]
65 Togami K, Maruta Y, Nanbu M, Tada H, Chono S. Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis. Drug Dev Ind Pharm 2020;46:1873-80. [PMID: 32940095 DOI: 10.1080/03639045.2020.1825473] [Reference Citation Analysis]
66 Tzouvelekis A, Gomatou G, Bouros E, Trigidou R, Tzilas V, Bouros D. Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer. Chest 2019;156:383-91. [DOI: 10.1016/j.chest.2019.04.114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
67 Samarelli AV, Masciale V, Aramini B, Coló GP, Tonelli R, Marchioni A, Bruzzi G, Gozzi F, Andrisani D, Castaniere I, Manicardi L, Moretti A, Tabbì L, Guaitoli G, Cerri S, Dominici M, Clini E. Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development. Int J Mol Sci 2021;22:12179. [PMID: 34830058 DOI: 10.3390/ijms222212179] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Piras IS, Bleul C, Siniard A, Wolfe AJ, De Both MD, Hernandez AG, Huentelman MJ. Association of Common Genetic Variants in the CPSF7 and SDHAF2 Genes with Canine Idiopathic Pulmonary Fibrosis in the West Highland White Terrier. Genes (Basel) 2020;11:E609. [PMID: 32486318 DOI: 10.3390/genes11060609] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Duan J, Zhong B, Fan Z, Zhang H, Xu M, Zhang X, Sanders YY. DNA methylation in pulmonary fibrosis and lung cancer. Expert Review of Respiratory Medicine. [DOI: 10.1080/17476348.2022.2085091] [Reference Citation Analysis]
70 Liu C, He Y. [Research Progress in the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Cancer]. Zhongguo Fei Ai Za Zhi 2020;23:695-700. [PMID: 32838491 DOI: 10.3779/j.issn.1009-3419.2020.102.23] [Reference Citation Analysis]
71 Lee HY, Lee J, Lee CH, Han K, Choi SM. Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study. Respirology 2021;26:180-7. [PMID: 33145926 DOI: 10.1111/resp.13911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
72 Yabe T, Itonaga T, Kuga S, Koga H, Kusaba T, Nishida H, Daa T, Maeda T, Ihara K. An autopsy case of recurrent pneumothorax and peliosis-like intrapulmonary hematoma with X-linked myotubular myopathy. Brain Dev 2021:S0387-7604(21)00209-6. [PMID: 34840057 DOI: 10.1016/j.braindev.2021.11.004] [Reference Citation Analysis]
73 Song MJ, Kim SY, Park MS, Kang MJ, Lee SH, Park SC. A nationwide population-based study of incidence and mortality of lung cancer in idiopathic pulmonary fibrosis. Sci Rep 2021;11:2596. [PMID: 33510351 DOI: 10.1038/s41598-021-82182-8] [Reference Citation Analysis]
74 Gong F, Yang Y, Wen L, Wang C, Li J, Dai J. An Overview of the Role of Mechanical Stretching in the Progression of Lung Cancer. Front Cell Dev Biol 2021;9:781828. [PMID: 35004682 DOI: 10.3389/fcell.2021.781828] [Reference Citation Analysis]
75 Liu G, Li S, Zhang N, Wei N, Wang M, Liu J, Xu Y, Li Y, Sun Q, Li Y, Li F, Yu P, Liu M, Wang Y, Zhai H, Wang Y. Sequential grade evaluation method exploration of Exocarpium Citri Grandis (Huajuhong) decoction pieces based on "network prediction → grading quantization → efficacy validation". J Ethnopharmacol 2022;:115149. [PMID: 35231589 DOI: 10.1016/j.jep.2022.115149] [Reference Citation Analysis]
76 Silva SC, Murinello N, Alfarroba S, Santos AS, Calvinho P, Semedo L. Lung transplant complicated with unexpected neoplasm in explanted lungs: A difficult challenge to manage. Pulmonology 2020;26:172-4. [PMID: 31732438 DOI: 10.1016/j.pulmoe.2019.10.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Kai Y, Matsuda M, Fukuoka A, Hontsu S, Yamauchi M, Yoshikawa M, Muro S. Remarkable response of non-small cell lung cancer to nintedanib treatment in a patient with idiopathic pulmonary fibrosis. Thorac Cancer 2021;12:1457-60. [PMID: 33742758 DOI: 10.1111/1759-7714.13935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]